investor-news-details

Please note that you are now entering a website directly or indirectly maintained by a third party (the "External Site") and that you do so at your own risk.

DuPont has no control over the External Site, any data or other content contained therein or any additional linked websites. The link to the External Site is provided for convenience purposes only.

By entering this site you acknowledge and agree that neither DuPont nor third party provider Virtua Research, Inc. (“Virtua) is responsible, or accepts or assumes any responsibility or liability whatsoever for, the content, the data or the technical operation of the External Site. Further, by entering the External Site, you also acknowledge and agree that you completely and irrevocably waive any and all rights and claims against DuPont and Virtua and further acknowledge and agree that in no event shall DuPont or Virtua, its officers, employees, directors and agents be liable for any (i) indirect, consequential, incidental, special, compensatory or punitive damages, (ii) damages for loss of income, loss of business profits, business interruption, loss of data or business information, loss of or damage to property, (iii) claims of third parties, or (iv) other pecuniary loss, arising out of or related to the Legal Notice, this disclaimer or the External Site.

By entering the External Site, you further acknowledge and agree that the disclaimer of warranties and limitations of liability set out in this disclaimer shall apply regardless of the causes, circumstances or form of action giving rise to the loss, damage, claim or liability, even if such loss, damage, claim or liability is based upon breach of contract (including, without limitation, a claim of fundamental breach or breach of a fundamental term), tort (including, without limitation, negligence), strict liability or any other legal or equitable theory, and even if DuPont and Virtua are advised of the possibility of the loss, damage, claim or liability. The waiver and release specifically includes, without limitation, any and all rights and claims pertaining to the processing of personal data, including but not limited to any rights under any applicable data protection statute(s).

If in any jurisdiction, any part of this disclaimer is held to be unenforceable by a court of competent jurisdiction, such part of this disclaimer shall be restricted or eliminated to the minimum extent and the remaining disclaimer shall otherwise remain in full force and effect.

Please note the information presented is deemed representative at the time of its original release. Changes in historical information may occur due to adjustments in accounting and reporting standards & procedures.

Mark Schneider Elected to DuPont Board of Directors

08/01/2014

WILMINGTON, Del., Aug. 1, 2014 /PRNewswire/ -- DuPont today announced the election of Ulf M. "Mark" Schneider, President and CEO of Fresenius SE & Co. KGaA to its board of directors, effective Oct. 22.

"Mark leads a significant global healthcare business and brings strong operating and international experience, including valuable perspective in emerging markets," said DuPont Chair and Chief Executive Officer Ellen Kullman.  "He will be a strong asset to DuPont as we continue to advance our strategy and bring the strength of our science to bear on some of the world's most pressing challenges."

Mr. Schneider, 48, has served since 2003 as President and CEO for Fresenius SE & Co. KGaA, a diversified global health care group, with $27.0 billion in revenue in 2013.  Fresenius operates in approximately 100 countries and specializes in lifesaving medicines and technologies for dialysis, clinical nutrition, infusion and transfusion.  Mr. Schneider joined Fresenius in 2001, serving as CFO of Fresenius Medical Care, a Fresenius Group company.  Previously, he was Group Finance Director of Gehe UK, a UK-based pharmaceutical distributor and held several senior executive positions with Franz Haniel & Cie, GmbH, a diversified German multinational company, since 1989.

Mr. Schneider graduated from the University of St. Gallen in Switzerland, where he also received a doctoral degree in Economics, and earned his MBA from Harvard Business School.

DuPont (NYSE: DD) has been bringing world-class science and engineering to the global marketplace in the form of innovative products, materials, and services since 1802.  The company believes that by collaborating with customers, governments, NGOs, and thought leaders we can help find solutions to such global challenges as providing enough healthy food for people everywhere, decreasing dependence on fossil fuels, and protecting life and the environment.  For additional information about DuPont and its commitment to inclusive innovation, please visit http://www.dupont.com.

Editors' note: A photograph of Mark Ulf M. "Mark" Schneider is available by clicking here.

SOURCE DuPont

Dan Turner, 302-774-0081, daniel.a.turner@usa.dupont.com

IR Contacts

Transfer Agent
ComputerShare
(888) 983-8766

Shareholder Relations
(302) 774-3034

Institutional Shareholders
(302) 774-4994

Email Alerts

Email Address *
Mailing Lists *